Please enable JavaScript.
Coggle requires JavaScript to display documents.
M. Tuberculosis (Scientific basis of disease
anatomy
physiology
…
M. Tuberculosis
Scientific basis of disease
- anatomy
- physiology
- pathology
- biochemistry
- microbiology
- immunology
- genetics
immunology
initiate type IV delayed hypersensitivity reaction, as they are difficult for phagocytes to kill
Neutrophils may be involved initially but soon the response is dominated by macrophages with surviving intracellular bacteria.
Causes granulomatous inflammation. Majority of the damage to host is done by the immune system rather than the bacterium
-
anatomy
-
initial immune response is at two separate sites: the site of entry (usually the periphery), called the Ghon focus; and within draining lymph nodes.
-
microbiology
Slow-growing (divides every 15-20 hrs), long-lived intracellular bacteria
biochemistry
protected by thick waxy outer layer - neither gram + or -. Identified by acid-fast test - Ziehl-Neelson stain
Acid fast organisms like Mycobacterium contain large amounts of lipid substances within their cell walls called mycolic acids. These acids resist staining by ordinary methods such as a Gram stain (can appear Gram + or -)
-
Treatment
Antibiotics
-
Resistance
Multi-drug resistant TB (MDR-TB)
- to more than one anti-TB drug
- at least isoniazid and rifampicin
Drug resistant TB
- to at least one first-line agent
Extensively drug resistant TB (XDR-TB)
- resistant to isoniazid and rifampicin
- resistant to any fluoroquinolone
- resistant to at least one injectable second-line drug
First-line anti-TB agents:
- isoniazid (INH)
- rifampin (RIF)
- ethambutol (EMB)
- pyrazinamide (PZA)
Regimen
Intensive phase:
- Daily INH, RIF, PZA, and EMB for 40-56 doses (8 weeks)
Continuation phase:
- Daily INH and RIF for 90-126 doses (18 weeks)
or
- three-times-weekly INH and RIF for 54 doses (18 weeks)
Public Health
Prevention
-
-
Treatment is important for prevention: Protect your family and friends from TB – take ALL your TB drugs!
Countries with high rate of TB:
- Africa – particularly sub-Saharan Africa (all the African countries south of the Sahara desert) and west Africa
- southeast Asia – including India, Pakistan, Indonesia and Bangladesh
- Russia
- China
- South America
- the western Pacific region (to the west of the Pacific Ocean) – including Vietnam, Cambodia and the Philippines
-
-
-